Royal Bank Of Canada Accelerate Diagnostics, Inc Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.64 - $1.03 $46 - $74	-72 Reduced 0.09%	76,924 $62,000
Q1 2023 May 15, 2023	SELL	$0.46 - $0.77 $115 - $192	-250 Reduced 0.32%	76,996 $53,000
Q4 2022 Feb 14, 2023	SELL	$0.51 - $17.1 $88,378 - $2.96 Million	-173,292 Reduced 69.17%	77,246 $54,000
Q3 2022 Nov 14, 2022	BUY	$1.01 - $17.0 $30,582 - $514,760	30,280 Added 13.75%	250,538 $381,000
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.41 $2,654 - $6,931	-4,916 Reduced 2.18%	220,258 $219,000
Q1 2022 May 16, 2022	SELL	$1.4 - $5.15 $15,745 - $57,922	-11,247 Reduced 4.76%	225,174 $324,000
Q4 2021 Feb 14, 2022	BUY	$4.27 - $6.97 $74,848 - $122,177	17,529 Added 8.01%	236,421 $1.23 Million
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $38,497 - $59,812	7,250 Added 3.43%	218,892 $1.28 Million
Q2 2021 Aug 16, 2021	BUY	$6.81 - $9.23 $1.44 Million - $1.95 Million	211,642 New	211,642 $1.71 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.